Congenericity of Claimed Compounds in Patent Applications
A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/17/5253 |
_version_ | 1797521040932339712 |
---|---|
author | Maria J. Falaguera Jordi Mestres |
author_facet | Maria J. Falaguera Jordi Mestres |
author_sort | Maria J. Falaguera |
collection | DOAJ |
description | A method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a more diverse set of compounds around a more vaguely described patent claim. An application to 750 common patents available in SureChEMBL, SureChEMBLccs and ChEMBL is presented and the congenericity of patent compounds in those different sources discussed. |
first_indexed | 2024-03-10T08:07:04Z |
format | Article |
id | doaj.art-9f2693c6e5314d798147a08f62978af0 |
institution | Directory Open Access Journal |
issn | 1420-3049 |
language | English |
last_indexed | 2024-03-10T08:07:04Z |
publishDate | 2021-08-01 |
publisher | MDPI AG |
record_format | Article |
series | Molecules |
spelling | doaj.art-9f2693c6e5314d798147a08f62978af02023-11-22T11:01:23ZengMDPI AGMolecules1420-30492021-08-012617525310.3390/molecules26175253Congenericity of Claimed Compounds in Patent ApplicationsMaria J. Falaguera0Jordi Mestres1Research Group on Systems Pharmacology, Research Program on Biomedical Informatics (GRIB), IMIM Hospital del Mar Medical Research Institute, Parc de Recerca Biomèdica (PRBB), Doctor Aiguader 88, 08003 Barcelona, Catalonia, SpainResearch Group on Systems Pharmacology, Research Program on Biomedical Informatics (GRIB), IMIM Hospital del Mar Medical Research Institute, Parc de Recerca Biomèdica (PRBB), Doctor Aiguader 88, 08003 Barcelona, Catalonia, SpainA method is presented to analyze quantitatively the degree of congenericity of claimed compounds in patent applications. The approach successfully differentiates patents exemplified with highly congeneric compounds of a structurally compact and well defined chemical series from patents containing a more diverse set of compounds around a more vaguely described patent claim. An application to 750 common patents available in SureChEMBL, SureChEMBLccs and ChEMBL is presented and the congenericity of patent compounds in those different sources discussed.https://www.mdpi.com/1420-3049/26/17/5253chemical seriespatent compoundssimilarity analysisSureChEMBLSureChEMBLccsChEMBL |
spellingShingle | Maria J. Falaguera Jordi Mestres Congenericity of Claimed Compounds in Patent Applications Molecules chemical series patent compounds similarity analysis SureChEMBL SureChEMBLccs ChEMBL |
title | Congenericity of Claimed Compounds in Patent Applications |
title_full | Congenericity of Claimed Compounds in Patent Applications |
title_fullStr | Congenericity of Claimed Compounds in Patent Applications |
title_full_unstemmed | Congenericity of Claimed Compounds in Patent Applications |
title_short | Congenericity of Claimed Compounds in Patent Applications |
title_sort | congenericity of claimed compounds in patent applications |
topic | chemical series patent compounds similarity analysis SureChEMBL SureChEMBLccs ChEMBL |
url | https://www.mdpi.com/1420-3049/26/17/5253 |
work_keys_str_mv | AT mariajfalaguera congenericityofclaimedcompoundsinpatentapplications AT jordimestres congenericityofclaimedcompoundsinpatentapplications |